NanoViricides Lands $4,300,000 New Financing

  • Feed Type
  • Date
    10/5/2009
  • Company Name
    NanoViricides
  • Mailing Address
    135 Wood Street West Haven, CT 06516
  • Company Description
    We have assembled a world class team to lead us to success. We have brought together highly experienced individuals with strong expertise in their respective areas. Our team possesses the combined expertise of having performed research, development, and regulatory processing for over 25 drugs, of which 10 are approved and the rest are at various advanced clinical stages, at the team members’ previous affiliations. Our team is also highly innovative, and boasts pioneering research in varied areas that are at the fore-fronts of medical science and pharmaceutical technology such as polymeric micelles, multi-specific multi-targeting, anti-sense DNA, siRNA, ribozymes, and gene therapy.
  • Website
    http://www.nanoviricides.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,300,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy